Variability of bothersome menopausal symptoms over time – a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT)
Journal Title: BMC Women's Health - Year 2012, Vol 12, Issue
Abstract
Very little data are available on the natural course or level of disturbance of vasomotor symptoms among middle-aged women. Using readily collected trial data we studied the persistence of vasomotor symptoms among untreated women.
Authors and Affiliations
Elina Hemminki, Elena Regushevskaya, Riitta Luoto, Piret Veerus
Keywords
Related Articles
- EP ID EP679545
- DOI 10.1186/1472-6874-12-44
- Views 63
- Downloads 0
Psychosocial impact of perinatal loss among Muslim women
Women of reproductive age are vulnerable to psychosocial problems, but these have remained largely unexplored in Muslim women in developing countries. The aim of this study was to explore and describe psychosocial impact...
Secular trends in age at menarche and time to establish regular menstrual cycling in Japanese women born between 1930 and 1985
Early life-stage exposure to estrogen increases the risk of breast cancer. The objective of this study was to investigate the age at menarche and time to onset of regular menstrual cycles for Japanese women born between...
Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer
Breast cancer today has many established risk factors, both genetic and environmental, but these risk factors by themselves explain only part of the total cancer incidence. We have investigated potential interactions bet...
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials
Approaches to the treatment of endometriosis vary worldwide, but studies comparing endometriosis medications in different ethnic groups are rare. A systematic literature search identified two studies directly comparing d...
Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology
Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. This is an aggressive malignancy with a...